Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: TIO/OLO;   Drug: ICS Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Early Intervention Efficacy in COPD
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium/Olodaterol;   Drug: Tiotropium Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2020 Category: Research Source Type: clinical trials

Effects of Spiolto ® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects
Condition:   Chronic Obstructive Pulmonary Disease Intervention:   Drug: Olodaterol-Tiotropium Sponsors:   Fraunhofer-Institute of Toxicology and Experimental Medicine;   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2020 Category: Research Source Type: clinical trials

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2020 Category: Research Source Type: clinical trials

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale.
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2020 Category: Research Source Type: clinical trials

A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat ® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium + olodaterol;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2020 Category: Research Source Type: clinical trials

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy
Condition:   Pulmonary Disease, Chronic Obstructive Interventions:   Drug: Tiotropium and Olodaterol (Tio+Olo);   Drug: Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS) Sponsor:   Boehringer Ingelheim Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials